Pfizer Malaysia

  • Home
  • Pfizer Malaysia

Pfizer Malaysia Breakthroughs that change patients' lives. Please contact your doctor or healthcare professional for this information or advice. Safety. Promotional information.

PRIVACY NOTICE

You understand and acknowledge that by clicking, reacting, commenting or sharing a post, article or link and/or posting on this page or any of its contents, you may be disclosing personal information which may be collected, processed and stored in a Pfizer-managed data base system and/or in the data base system of their/its affiliates or authorized third parties, and whic

h shall be used and administered solely by Pfizer, and its affiliate companies and authorized third parties for the purpose of managing the Facebook account and complying with Pfizer’s regulatory obligations, including reporting of adverse events to the Food and Drug Administration, if applicable. By clicking, reacting, commenting or sharing a post, article or link and/or posting on this page or any of its contents, you give your consent to Pfizer’s (a) collection, processing, storage and use of personal information; and (b) outsourcing of the collection, processing, storage and use of personal information to service providers whether within or outside Malaysia. The foregoing constitutes your express consent under the applicable confidentiality and data privacy laws of Malaysia and other jurisdictions, and agree to hold Pfizer and relevant parties free and harmless from any and all liabilities, claims, damages and suits of whatever kind and nature that may arise in connection with the implementation and compliance with the authorization you confer hereunder. The foregoing is without prejudice to your rights to reasonable access to, upon demand, and correction of your personal information, as well as your right to lodge a complaint. Please refer to our Privacy Policy: https://www.pfizer.com.my/privacy-policy

Please read Pfizer’s Privacy Policy before proceeding to click, react, comment or share a post, article or link and/or post on this page or any of its contents. COMMUNITY GUIDELINES

This page was created to share news and information with the general public about Pfizer activities and healthcare related issues in Malaysia, is intended for residents of Malaysia and is subject to the following Pfizer Community Guidelines. If you have any medical inquiries about Pfizer pharmaceutical products, please contact our Medical Information Services: Submit Medical Inquiry - medical.query@pfizer.com. Malaysia laws and regulations do not allow pharmaceutical companies to offer information or advice on the diagnosis of disease or choice of therapy to consumers or patients, or to engage in direct-to-consumer advertisements. In Pfizer Community Guidelines, Pfizer means:

Pfizer (Malaysia) Sdn Bhd
Level 10 & 11,
Wisma Averis, Tower 2, Avenue 5,
Bangsar South, No.8, Jalan Kerinchi, 59200 Kuala Lumpur. Company website: www.pfizer.com.my
Contact details to send data protection rights: malaysia_privacy.officer@pfizer.com

Pfizer Community Guidelines shall be governed by and construed in accordance with the laws of Malaysia and any disputes arising therefrom subject to the exclusive jurisdiction of Malaysia courts. Pfizer Community Guidelines
The data contained in this Pfizer social media channel are informational and should not be viewed as professional or medical advice. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. Reliance on any information provided herein is solely at your own risk. Before commenting, sharing pictures, videos and articles on this Pfizer social media channel, please make sure that whatever you share is in line with Facebook’s Terms of Use and these Community Guidelines. BY FOLLOWING THIS PFIZER FACEBOOK PAGE, CLICKING, REACTING, COMMENTING OR SHARING A POST, ARTICLE OR LINK AND/OR POSTING ON THIS FACEBOOK PAGE OR ANY OF ITS CONTENTS, YOU ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO THE PFIZER COMMUNITY GUIDELINES POSTED AT THE TIME YOU VISIT THIS PFIZER SOCIAL MEDIA CHANNEL, WHICH APPLIES IN ADDITION TO THE TERMS AND CONDITIONS OR OTHER LEGAL NOTICES THAT ARE PROVIDED BY PFIZER AND/OR THE OWNER OF THE SOCIAL MEDIA PLATFORM. Pfizer endorses only its own content: Pfizer does not represent or endorse users’ comments on its timeline and is not responsible for such posts. In particular, USERS WILL REMAIN SOLELY RESPONSIBLE FOR THE CONTENT THEY POST AND WILL HOLD PFIZER HARMLESS FROM ANY CONSEQUENCE AND PREJUDICE THAT MAY ARISE AGAINST PFIZER OR OTHER USERS IN RESPECT OF USER POSTED CONTENT THAT IS IN BREACH OF OUR COMMUNITY GUIDELINES AND/OR TERMS OF SERVICE OF THE OWNER OF THE SOCIAL MEDIA PLATFORM.

1. What we expect from our users: general guidelines

The Pfizer Community Guidelines have been created to ensure compliance with the regulations of our industry and our own standards. Here are a few things you should comply with when posting on one of our channels:

• Do not post references to a medicinal product. If your post refers to a product / brand from any company – positively or negatively – we might be required to remove it due to applicable regulations.

• Do not post references to a possible side effect. To report an adverse event or product complaint related to a Pfizer product, use your country contact details found at the top of these community guidelines, or contact your local health authority.

• Do not post any medical advice. If you have any questions about a specific Pfizer medication (bearing the Pfizer logo), please contact your local Pfizer Office or Medical Information. For contact details of Pfizer Medical Information by country, please see the contact details found at the top of these community guidelines. As always, we recommend consulting with your physician on any medical condition.

• Do not post any personal information or private information of you or of any other person. To protect your privacy, and the privacy of others, do not include personally identifiable information about yourself or any other person (including celebrities, either living or dead), such as phone numbers, email addresses, photographs, information about health or any disease or other personal information in any comments posted to our social media channels, including Chat bots. Pfizer social media accounts are public so please be aware that your posts are non-confidential and will be available for unrestricted viewing. Chat bots shall not be accessed by the general public but may be accessed by the social media owner in accordance with its own terms and conditions.

• Do not post trade secrets or intellectual property rights without authorization. Do not post comments that contain trade secrets or ideas/materials/works protected by third party copyright or other intellectual property rights, such as art, music, videos, photographs, written text, performances, links to other websites or by any trade-marks or logos, models, designs, etc., except with the express consent of the owners of such intellectual property.

• Do not post other contents that might result in a breach of the law. Post that contain predatory conduct towards minors; libel, slander, or defamation of character; terrorism; threats; text, pictures or images that could be described as obscene, profane, lewd, crude, provocative, pornographic or pedopornographic, or as containing gang signs or symbols, gun imagery, political or religious propaganda, derogatory characterizations of any ethnic, racial, sexual or religious group, depictions of alcohol or drug abuse, or promotion of illegal activity or behavior of any kind, are prohibited.

• Do not post off-topic comments. Please keep your comments relevant to the post that you're commenting on. Avoid posts that are clearly off topic (including but not limited to unsupported accusations or promotion of third party initiatives, services or products).

• Do not send feedback about our products or companies, solicit business, or request donations.

• Do not post vulgarity or offensive contents. Vulgar, harassing, abusive language, comment containing profanity or that are deemed inappropriate are not permitted. Posts may be screened for personal attacks of any kind or offensive terms that target specific ethnic, racial, religious, age or gender orientation groups.

• Do not post contents that might create technical disruptions. Do not post comments that contain spam, software viruses, Trojan horses, worms, time bombs or any other computer code or files or disabling mechanisms that are designed to disrupt, damage or limit the functioning of any software, hardware, telecommunications equipment or that interferes with the operation of the social media site.

• Do not post contents on minors. If your post contains the name or likeness of a minor (as defined in your jurisdiction), you must be the parent or legal guardian of that minor and have all legal rights to act on his/her behalf without the other parent or legal guardian or relevant authority, as the case may be. Pfizer reserves the right to delete any posts at its sole discretion even if the situation is not outlined above.

2. Moderation, Monitoring and Reporting

Pfizer will be actively monitoring this page to help ensure that users’ posts comply with these Community Guidelines and with applicable legislation, including requirements for safety reporting to health authorities. As such, Pfizer, in its sole discretion, reserves the right to remove any post which is deemed to be not compliant with the Community Guidelines and the current applicable legislation and to block/ban any user from the page. Where the need arises, we will respond to your post but we will not reply to all messages received. If you edit your comment after posting it, we may not be notified of the change and may not address your edited comment. In addition, Pfizer reserves the right to report any comment/post that it believes is in breach of Facebook’s Terms of Use where it entails a breach of law to report it to the relevant Authorities and to pursue any legal action which is deemed necessary to defend Pfizer rights and interests. In particular your comment, response, or other posting may be submitted to law enforcement if we have a good faith belief that disclosure of such information is reasonably necessary to detect and prevent fraud or to protect the safety/rights of the public or an individual.

3. Right of Pfizer to use your posts

By posting your content on Pfizer’s page, you acknowledge that Pfizer shall be entitled to use those posts and any ideas, techniques, works or materials contained in them (and assigns to Pfizer any rights that you might hold on these ideas, techniques, works or materials) for free, in any way and in any Pfizer media, without any time and territorial limit, regarding any exploitation right (including but not limited to their reproduction, making available to the public, distribution, public communication, transformation, extraction and re-use), and for any purpose whatsoever. Accordingly, please do not submit any ideas, techniques or materials that you wish to keep confidential, for which you expect to receive compensation or on which you do not have the appropriate rights to share.

4. Privacy

Public information and Chatbots. Pfizer social media accounts are public: all posts are non-confidential and will be available for unrestricted viewing. When you post in any of our social media channels, you consent to the fact that your name, likeness and social media handle will be visible and associated with your post and that we (and any other users) may re-use your post elsewhere and thus, we (and any other users) may display your name, likeness and handle there as well, for any purpose. The personal information you might post in Pfizer social media accounts (that you do at your sole discretion) shall not be stored (apart from anonymously) by Pfizer but used, as an inherent part of the post, to merely manage Pfizer social media accounts and, if applicable, enforce Pfizer Community Guidelines; to better understand general trends on how Pfizer digital contents are followed, liked or used, in particular, by analysing the statistics provided to us by the social media platform owner (as part of its services to its social media users) explained below; and to comply with our legal duties (such as the report of product safety events). If you use a Chat bot in Pfizer social media accounts, we remind you not to provide information that identifies you or another individual. In the Chat bot, you may be engaged in a conversation with artificial intelligence programmed by Pfizer and which will be accessed and stored by Pfizer to manage the Chat bot and improve the artificial intelligence learning experience. However, the owner of the social media may have also access thereto in accordance with its own terms and conditions. Social media platform tracking technologies. The social media platform owner provides to all of its social media registered users (including you, if you are also a registered user) with statistics on how Pfizer digital contents are followed, liked or used. The information used to create these statistics is directly obtained by the social media platform owner through the tracking technologies of its sole choice (such as cookies placed in your device). Although we may indicate to the social media platform owner the parameters for the statistics that we would like to receive (and apply any filters as made available by the social media platform owner), it is the platform owner that collects the actual personal information and compiles the statistics. We only receive any statistics from the platform owner in anonymized format. Please refer to the social media platform owner (e.g., its terms and conditions, privacy policy or cookie policy) to know more about the tracking technologies they use and your choices to deactivate them. Your rights (other than for safety purposes and social media platform tracking technologies). If you have any data protection query in this respect (e.g., access, rectification, erasure, restriction, portability and objection), please address it to the Pfizer entity indicated at the beginning of the Pfizer Community Guidelines. However, you must be aware that some or all of the general data protection rights could be limited in this case since we do not store personal data posted in the Pfizer social media accounts, including Chat bots; unless you tell us, we do not know who you are; and none of these activities requires any consent from you (other than your free will to publicly post in Pfizer social media accounts, including Chat bots, personal information, which is subject to your compliance with these Pfizer Community Guidelines and the terms of use of the social media platform owner). If the Chat bot is using functionalities of the social media platform (e.g., any chat bot in Facebook works on the Facebook Messenger service), your access and the scope of your deletion rights regarding the messages and the whole conversation (not only in your inbox but also in the inbox of the recipients of your Chat bot messages) shall depend on these functionalities of the social media platform. If you are engaged in a 1:1 conversation in a Pfizer Chat bot (rather than 1 to many) and these functionalities do not enable you to delete a message from Pfizer Chat bot’s inbox, please address your request to the Pfizer entity indicated at the beginning of the Pfizer Community Guidelines. You may lodge a complaint with a supervisory data protection authority if you disagree with our specific response to a data protection query. If, despite the prohibition of these Community Guidelines, you report an adverse event or product complaint in your posts or in interactions with a Chat bot, personal information about you will be retained (and additional information may be requested from you for safety follow-up purposes) so that the Pfizer organization world-wide (https://selfservehosteu.pfizer.com/legal-entities) -including in other countries different from your home country which may have different personal data standards - can fulfil its safety legal requirements. If you have any data protection query in this respect (e.g., access, rectification, erasure, restriction, portability and objection), use the data protection country contact details found in at the top of these community guidelines. However, you must be aware that some of the general data protection rights could be limited in this case since the data processing purpose is to comply with safety legal duties. International transfers and safeguards. Pfizer uses centralised technology in its organisation and vendors to host and technically support the technology that enables us to manage the Pfizer social media accounts and chat bots. This centralised technology and vendors may potentially be located in any country from time to time, including in other countries different from your home country which may have different personal data standards. Some non-EEA countries are recognized by the European Commission as providing an adequate level of data protection according to EEA standards (the full list of these countries is available here at https://ec.europa.eu/info/law/law-topic/data-protection/data-transfers-outside-eu/adequacy-protection-personal-data-non-eu-countries_en). For transfers from the EEA to countries not considered adequate by the European Commission (such as the US), Pfizer has put in place adequate measures both within its group and with non-EEA or non-Swiss vendors
(http://ec.europa.eu/justice/data-protection/international-transfers/transfer/index_en.htm
http://eur-lex.europa.eu/legal-content/HU/TXT/HTML/?uri=CELEX:32004D0915&from=EN). Alternatively, Pfizer requires substantially equivalent guarantees under EU and Swiss data protection regulations (e.g., BCRs, adequacy decision of the European Commission, data protection codes of conduct or certifications, Privacy Shield certifications). You may obtain further information of these measures by contacting the Pfizer entity indicated at the beginning of the Pfizer Community Guidelines. If you receive Pfizer promotional information through this social media platform, it is because you are one of our “followers” and/or you have otherwise provided your consent to the owner of the social media platform to receiving other user’s marketing contents. In the latter case, check your marketing choices with the owner of the social media platform to keep your marketing preferences in this social media platform up-to-date at any time. Otherwise, you may have permitted Pfizer, in other interactions with Pfizer (outside this Pfizer social media channel), to contact you through social media platforms to send you Pfizer promotional information. If you wish to revoke the permission granted to Pfizer please unsubscribe by contacting us at the unsubscribe email found at the top of these community guidelines. Pfizer Malaysia Data Protection Officer. The contact information of our data protection officer is malaysia_privacy.officer@pfizer.com.

5. Our limited responsibility regarding the posted contents

• The comments (including opinions and statements) and responses that you read on Pfizer channels that are not posted by Pfizer, come from members of the public. Although we are moderating our channels to help compliance with these Community Guidelines, we cannot be and are not responsible for the accuracy or reliability of any comments or materials posted by users.

• Pfizer will use reasonable efforts to include accurate information on our accounts but gives no warranties, undertakings or representations of any kind as to its accuracy, currency, quality, completeness or fitness for purpose. Any information provided by Pfizer and/or made available through our social media accounts is provided on an “as is” basis. Pfizer disclaims all warranties, express or implied to the full extent permitted by law. Pfizer shall be not liable for any loss, damage or cost whatsoever, whether in contract, tort (including negligence) or otherwise arising from reliance on information posted on our social media accounts. This limitation includes any loss, damage or cost caused by any viruses that infect your computer equipment, software or data. Any banner advertising and/or links to third party websites posted on the Pfizer social media accounts do not amount to any endorsement of that website by Pfizer and any use of that website by you is at your own risk and under your responsibility, not having Pfizer any control over them and not being responsible for their contents. For Pfizer's terms of use click here: Terms of Use | Pfizer – Breakthroughs that Change Patients’ Lives https://www.pfizer.com.my/terms-of-use

08/08/2025

Pneumococcal disease can affect anyone, but some groups face higher risks:
👶 Infants¹
👵 Older adults¹
❤️‍🩹 Adults with medical conditions (such as diabetes, heart, lung, or kidney disease)²⁻³
🕋 Hajj and Umrah pilgrims⁴
🌍 Frequent travellers⁵

Staying healthy allows us to grow, to celebrate life’s milestones and to be present for the people who matter most. Yet, an illness like pneumococcal disease can take these moments away.

Let’s protect every stage of life, for ourselves and those who matter most³. It all begins with one choice.

Speak to your doctor today to learn more about how you can protect yourself and your loved ones from pneumococcal disease or visit www.preventlah.com.my for more information. Jom Prevent Lah!

References:
1. Centers for Disease Control and Prevention. Pneumococcal Disease: Causes and How It Spreads. Available at: https://www.cdc.gov/pneumococcal/causes/index.html -risk-factors. Accessed on 29 July 2025.
2. Prevent Pneumonia. Am I At Risk? Available at: https://preventpneumonia.com.my/am-i-at-risk/. Accessed on 29 July 2025.
3. Cleveland Clinic. Pneumococcal Disease. Available at: https://my.clevelandclinic.org/health/diseases/24231-pneumococcal-disease. Accessed on 29 July 2025.
4. Al-Tawfiq J. A & Memish Z. A. 2015. Prevention of pneumococcal infections during mass gathering. Human Vaccines & Immunotherapeutics, 12(2), 326–330. DOI: 10.1080/21645515.2015.1058456.
5. BetterHealth Channel. Overseas travel – health tips. Available at: https://www.betterhealth.vic.gov.au/health/healthyliving/travel-health-tips. Accessed on 29 July 2025.



PP-UNP-MYS-0639-29JUL2025

07/08/2025

“Bolehkah saya dijangkiti COVID-19 semula walaupun pernah dijangkiti sebelum ini?” Jawapannya ialah YA¹⁻²! Jangkitan semula boleh meningkatkan risiko kemasukan ke hospital dan menyebabkan kematian³⁻⁴.

Jadi, bagaimana anda boleh lindungi diri anda? Jika anda atau orang tersayang didapati positif COVID-19, segera dapatkan nasihat serta rawatan daripada pengamal perubatan profesional⁵⁻⁶.

Ilmu ialah senjata yang paling berharga. Kekal peka dengan maklumat terkini dan lindungi orang tersayang! Ketahui risiko anda untuk mengalami jangkitan COVID-19 yang serius serta langkah-langkah yang boleh diambil untuk melindungi diri anda dan orang tersayang di sini: https://www.knowplango.my/high-risk-checker.

Rujukan
1. Centers for Disease Control and Prevention. About Reinfection. Diperolehi daripada: https://www.cdc.gov/covid/about/reinfection.html. Diakses pada 22 Jun 2025.
2. Centers for Disease Control and Prevention. Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years — 18 U.S. Jurisdictions, September 2021–December 2022. Diperolehi daripada: https://www.cdc.gov/mmwr/volumes/72/wr/mm7225a3.htm. Diakses pada 22 Jun 2025.
3. Bowe B, et al. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nature Medicine, 28(11):2398–2405. DOI: 10.1038/s41591-022-02051-3.
4. Centers for Disease Control and Prevention. Factors That Affect Your Risk of Getting Very Sick from COVID-19. Diperolehi daripada: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/your-health/risks-getting-very-sick.html. Diakses pada 22 Jun 2025.
5. Centers for Disease Control and Prevention. People with Certain Medical Conditions. Diperolehi daripada: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Diakses pada 22 Jun 2025.
6.CodeBlue. Do We Still Need To Worry About Covid-19? – Dr Leong Chee Loon & Dr Muhammad Yazli Yuhana. Diperolehi daripada: https://codeblue.galencentre.org/2023/05/do-we-still-need-to-worry-about-covid-19-dr-leong-chee-loon-dr-muhammad-yazli-yuhana/. Diakses pada 22 Jun 2025.

PP-C1D-MYS-0308-23JUN2025

31/07/2025

Sebahagian masyarakat menganggap bahawa virus COVID-19 kini semakin lemah dan tidak lagi merbahaya.

Namun, virus SARS-COV-2 sukar dijangka dan terus bermutasi¹⁻². Bagi pesakit berisiko tinggi seperti warga emas dan individu yang menghidapi penyakit kronik, jangkitan ringan boleh menjadi serius dalam masa yang singkat³⁻⁶. Sekiranya anda tergolong dalam kumpulan berisiko tinggi dan didapati positif COVID-19, segera dapatkan nasihat serta rawatan daripada pengamal perubatan profesional⁷.

Ketahui risiko anda untuk mengalami jangkitan COVID-19 yang serius serta langkah-langkah yang boleh diambil untuk melindungi diri anda dan orang tersayang di sini: https://www.knowplango.my/high-risk-checker.

Rujukan
1. Centers for Disease Control and Prevention. SARS-CoV-2 Variant Classifications and Definitions. Diperolehi daripada: https://stacks.cdc.gov/view/cdc/105817. Diakses pada 22 Jun 2025.
2. European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 28 May 2025. Diperolehi daripada: https://www.ecdc.europa.eu/en/covid-19/variants-concern. Diakses pada 22 Jun 2025.
3. Centers for Disease Control and Prevention. Factors That Affect Your Risk of Getting Very Sick from COVID-19. Diperolehi daripada: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/your-health/risks-getting-very-sick.html. Diakses pada 22 Jun 2025.
4. Siddiqi HK, et al. COVID-19 illness in native and immunosuppressed states: A clinical−therapeutic staging proposal. J Heart Lung Transplant, 39(5), 405–407. DOI: 10.1016/j.healun.2020.03.012.
5. Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Diperolehi daripada: https://stacks.cdc.gov/view/cdc/89980. Diakses pada 22 Jun 2025.
6. Bestetti RB, et al. Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive Review. Int J Environ Res Public Health, 18(7212), 1-12. DOI: 10.3390/ijerph18137212.
7. Centers for Disease Control and Prevention. COVID-19 Treatments and Medications. Diperolehi daripada: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html. Diakses pada 22 Jun 2025.

PP-C1D-MYS-0308-23JUN2025

24/07/2025

COVID-19 masih merupakan ancaman kepada kesihatan awam¹. Sekitar 1.7 bilion orang berisiko tinggi mendapat jangkitan COVID-19 yang serius, terutamanya warga emas dan individu yang menghidap masalah kesihatan²⁻³. Dapatkan nasihat dan rawatan perubatan dengan segera sekiranya anda mengalami simptom⁴.

Dapatkan nasihat profesional daripada doktor anda kerana COVID-19 kini boleh dirawat! ⁵⁻⁶. Ketahui risiko anda untuk mengalami jangkitan COVID-19 yang serius serta langkah-langkah yang boleh diambil untuk melindungi diri anda dan orang tersayang di sini: https://www.knowplango.my/high-risk-checker.

Rujukan
1. World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. Diperolehi daripada: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Diakses pada 22 Jun 2025.
2. Clark A, et al. 2020. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health, 8( 8 ), e1003-e1017. DOI: 10.1016/S2214-109X(20)30264-3.
3. World Health Organization. Coronavirus disease (COVID-19). Diperolehi daripada: https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19). Diakses pada 22 Jun 2025.
4. New Straits Times. People in living with Covid-19 virus phase - Dr Dzulkefly. Diperolehi daripada: https://www.nst.com.my/news/nation/2024/06/1060974/people-living-covid-19-virus-phase-dr-dzulkefly. Diakses pada 22 Jun 2025.
5. Centers for Disease Control and Prevention. People with Certain Medical Conditions. Diperolehi daripada: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Diakses pada 22 Jun 2025.
6. CodeBlue. Do We Still Need To Worry About Covid-19? – Dr Leong Chee Loon & Dr Muhammad Yazli Yuhana. Diperolehi daripada: https://codeblue.galencentre.org/2023/05/do-we-still-need-to-worry-about-covid-19-dr-leong-chee-loon-dr-muhammad-yazli-yuhana/. Diakses pada 22 Jun 2025.

PP-C1D-MYS-0308-23JUN2025

14/07/2025

𝗕𝗲𝘄𝗮𝗿𝗲 𝗼𝗳 𝗖𝗼𝘂𝗻𝘁𝗲𝗿𝗳𝗲𝗶𝘁 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀!

Counterfeit drugs are fake medications that mimic legitimate ones but often lack the necessary active ingredients, posing serious health risks.¹

🔎 How to protect yourself:

✅ Purchase medications only from licensed pharmacies.​²
✅ Be cautious of unusually low prices; they may indicate counterfeit products.​³
✅ Consult your healthcare provider if you notice unexpected side effects or if the medicine's appearance seems different.³

Learn more about counterfeit drugs here: https://www.pfizer.com.my/counterfeiting



References:

1. Pfizer. Fake drugs 101: Facts on illegal, counterfeit drugs. Pfizer. Retrieved July 3, 2025, from https://www.pfizer.com/news/articles/fake_drugs_101_facts_on_illegal_counterfeit_drugs
2. Pfizer. Counterfeit medicines Q&A. Pfizer. Retrieved July 3, 2025, from https://www.pfizer.com/news/articles/counterfeit_medicines_q_a
3. Pfizer. How to safely buy medicine online. Pfizer. Retrieved July 3, 2025, from https://www.pfizer.com/news/articles/how_to_safely_buy_medicine_online

PP-UNP-MYS-0570-30APR2025

Innovation thrives wherever employees feel empowered to share ideas, take risks, and learn from mistakes. At Pfizer, we ...
09/07/2025

Innovation thrives wherever employees feel empowered to share ideas, take risks, and learn from mistakes. At Pfizer, we champion by encouraging employees to be their true selves and voice their thoughts.



PP-UNP-MYS-0606-23JUN2025

03/07/2025

At Pfizer, our purpose is clear - breakthroughs that change patients’ lives, but behind every breakthrough is an unwavering commitment to quality, trust, and responsibility.

In Malaysia, we continue to uphold the highest standards in the medicines we deliver, ensuring every product is backed by science and built on integrity.

Our ESG efforts further this commitment by supporting public health education, building community partnerships and contributing to more resilient healthcare systems. We understand that true progress means making healthcare more accessible, equitable and sustainable for all.

Because every Malaysian deserves care that is not only innovative, but trusted.

Many perceptions exist about the pharmaceutical and biopharmaceutical industry - some accurate, others less so. But what...
02/07/2025

Many perceptions exist about the pharmaceutical and biopharmaceutical industry - some accurate, others less so.

But what truly goes into developing a medicine? Who are the individuals behind each breakthrough? And how do treatments make their way to patients?

Swipe through as we address some of the most common misconceptions and share the facts that shape the work we do.



PP-UNP-MYS-0606-23JUN2025

Our 2024 Impact Report is live! ➡️ Pfizer.com/ImpactReport For 175 years, our Purpose — delivering breakthroughs that ch...
26/06/2025

Our 2024 Impact Report is live! ➡️ Pfizer.com/ImpactReport

For 175 years, our Purpose — delivering breakthroughs that change patients’ lives — has inspired everything we do.

In 2024, that Purpose came to life through our commitment to:
🔬 Advancing Scientific Innovation
💊 Expanding Access to Medicines and Vaccines
🌱 Working toward Net Zero by 2040
🌟 Fostering a Culture of Growth

Behind each number is a patient, a story, and a step toward better health.

Our partnerships with the communities we serve form the foundation of this work—driving long-term impact and helping build a more equitable world for all.

See the progress we’ve made toward our Environmental, Social, and Governance (ESG) goals in the report: https://www.pfizer.com/about/responsibility/responsible-business

Sesetengah orang beranggapan COVID-19 boleh dirawat dengan mengambil suplemen atau ubat OTCs. Walaupun ianya boleh memba...
25/06/2025

Sesetengah orang beranggapan COVID-19 boleh dirawat dengan mengambil suplemen atau ubat OTCs. Walaupun ianya boleh membantu mengawal simptom,¹ Kementerian Kesihatan mengesyorkan lawatan ke fasiliti kesihatan terdekat untuk mendapatkan nasihat berkenaan rawatan COVID-19.²

Dapatkan nasihat perubatan dan layari KnowPlanGo.my untuk mengetahui jika anda layak menerima rawatan.³

Rujukan:
1. Dietary Supplements in the Time of COVID-19. NIH. Retrieved from: https://ods.od.nih.gov/factsheets/COVID19-HealthProfessional/. Accessed on Nov 20, 2023.
2. Garis Panduan Pengurusan COVID-19. Ministry of Health Malaysia. Retrieved from:
https://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm/Garis-Panduan-Hidup-Bersama-COVID-19-15072024.pdf. Accessed on 21 October 2024.
3. COVID-19 Treatments and Medications. CDC. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html . Accessed on Dec 1, 2023.

PP-C1D-MYS-0182-2SEP2024

Pfizer marks an important step forward by formalising a strategic partnership with Universiti Putra Malaysia (UPM), in s...
24/06/2025

Pfizer marks an important step forward by formalising a strategic partnership with Universiti Putra Malaysia (UPM), in support of advancing public health through education, awareness, and scientific collaboration.

This MoU is part of Pfizer Malaysia’s continued efforts to empower healthier communities through programs that improve disease literacy, encourage preventive care, and expand access to healthcare.

Together with UPM, we are expanding what’s possible, nurturing future scientific talent and delivering on our commitment to breakthroughs that change lives. At Pfizer, we believe science wins when it’s shared, and partnerships like this bring us closer to a healthier, more equitable future for all.

Vaksinasi adalah barisan pertahanan pertama melawan COVID-19, namun ini tidak bermakna anda dilindungi sepenuhnya daripa...
18/06/2025

Vaksinasi adalah barisan pertahanan pertama melawan COVID-19, namun ini tidak bermakna anda dilindungi sepenuhnya daripada virus COVID-19.¹

Individu berisiko tinggi masih boleh dijangkiti dan mengalami komplikasi serius.¹⁻⁴ Rawatan COVID-19 dengan segera boleh membantu mengurangkan risiko komplikasi COVID-19.⁵

Dapatkan nasihat perubatan dan layari KnowPlanGo.my untuk mengetahui jika anda layak menerima rawatan.⁶

Rujukan:
1. Vaccine effectiveness, efficacy, and protection. WHO. Retrieved from:
https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection. Accessed on Nov 20, 2023.
2. Stay Up to Date with COVID-19 Vaccines. CDC. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html. Accessed on Nov 20, 2023.
3. COVID-19 Vaccine Effectiveness Update - COVID Data Tracker. CDC. Retrieved from:
https://covid.cdc.gov/covid-data-tracker/ -effectiveness. Accessed on Nov 20, 2023.
4. Factors That Affect Your Risk of Getting Very Sick from COVID-19. CDC. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/risks-getting-very-sick.html. Accessed on Nov 20, 2023.
5. Therapeutics and COVID-19: Living Guideline. 10 November 2023. WHO. Retrieved from: https://iris.who.int/bitstream/handle/10665/373975/WHO-2019-nCoV-therapeutics-2023.2-eng.pdf?sequence=1. Accessed on Nov 20, 2023.
6. COVID-19 Treatments and Medications. CDC. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html . Accessed on Dec 1, 2023.

PP-C1D-MYS-0181-2SEP2024

Address


Alerts

Be the first to know and let us send you an email when Pfizer Malaysia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pfizer Malaysia:

  • Want your practice to be the top-listed Clinic?

Share